Home › Rheumatoid Arthritis › Illinois › Chicago
Rheumatoid Arthritis clinical trials in Chicago, IL
5 studies for Rheumatoid Arthritis are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of AZD0120 in Autoimmune Diseases
RecruitingPhase 1/2
- Research Site, Chicago
Study of PTC844 in Participants With Active Rheumatoid Arthritis
RecruitingPhase 2
- Chicago Arthritis and Regenerative Medicine, Chicago
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
RecruitingPhase 2
- Northwestern Medicine - Northwestern Memorial Hospital /ID# 275422, Chicago
Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis
RecruitingPhase 1
- Northwestern University, Chicago
A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
RecruitingObservational study
- Northwestern University, Chicago
About Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a form of arthritis that causes pain, swelling, and stiffness in your joints. Your risk increases as you become an older adult.
More about Rheumatoid Arthritis on MedlinePlus
Rheumatoid Arthritis trials in other cities
- Houston, TX12 studies
- New York City, NY10 studies
- Durham, NC8 studies
- Miami, FL8 studies
- Plantation, FL7 studies
- Altoona, PA7 studies
- Dallas, TX7 studies
- Boston, MA7 studies
- Aurora, CO7 studies
- Mesquite, TX6 studies
- San Diego, CA6 studies
- Ann Arbor, MI5 studies
Other studies in Chicago
- Breast Cancer59 studies
- Non-Small Cell Lung Cancer59 studies
- Cancer (all types)51 studies
- Prostate Cancer45 studies
- Lung Cancer43 studies
- Metastatic Cancer42 studies
- Obesity40 studies
- Ovarian Cancer36 studies
- Colorectal Cancer32 studies
- Stroke31 studies
- Head and Neck Squamous Cell Carcinoma29 studies
- Overweight29 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.